Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

Autor: Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, José Medina-Polo, Jesús M. Fernández-Gómez, Vincenzo Ficarra, Joan Palou, Javier Ponce de León Roca, Javier C. Angulo, Manuel Esteban-Fuertes, José M. Cózar-Olmo, Noemí Pérez-León, José M. Molero-García, Antonio Fernández-Pro Ledesma, Francisco J. Brenes-Bermúdez, José Manasanch

Publikováno v: Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)

Abstract In a subset analysis of data from a 6-month, multicenter, non-interventional study, we compared change in symptoms and quality of life (QoL), and treatment tolerability, in men with moderate to severe lower urinary tract symptoms associated

Externí odkaz: https://doaj.org/article/dbfb0dfd6b60488a9466f0e9d3128226

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study

Autor: Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, Manuel Esteban-Fuertes, José Cózar-Olmo, Vincenzo Ficarra, Rafael Medina-López, Jesús Fernández-Gómez, Javier Angulo, José Medina-Polo, Francisco Brenes-Bermúdez, José Molero-García, Antonio Fernández-Pro-Ledesma, José Manasanch, on behalf of The QUALIPROST Study Group

Publikováno v: Journal of Clinical Medicine, Vol 9, Iss 2909, p 2909 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine
Volume 9
Issue 9
Digital.CSIC. Repositorio Institucional del CSIC
instname

To investigate whether tamsulosin (TAM) and the hexanic extract of Serenoa repens (HESr) are more effective in combination than as monotherapy in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c538aecf3f320b53a72e76969861e810
https://www.mdpi.com/2077-0383/9/9/2909

Heme oxygenase-1 prostatic levels are significantly lower in patients affected by moderate-severe LUTS secondary to benign prostatic hyperplasia: A pilot study

Autor: Russo, GIORGIO IVAN, Vanella, Luca, Campisi, D, Fragalà, E, Privitera, S, Favilla, V, Castelli, T, Cimino, Sebastiano, Sorrenti, Valeria, Morgia, Giuseppe Maria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f18f1ae5ac9f4b9cc0bb5857c0c197d1
http://hdl.handle.net/20.500.11769/99335

MP19-05 HEME OXYGENASE-1 PROSTATIC LEVELS ARE SIGNIFICANTLY LOWER IN PATIENTS AFFECTED BY MODERATE-SEVERE LUTS SECONDARY TO BENIGN PROSTATIC HYPERPLASIA: A PILOT STUDY

Autor: Russo, Giorgio Ivan, Vanella, Luca, Cimino, Sebastiano, Campisi, Daniele, Fragalà, Eugenia, Privitera, Salvatore, Favilla, Vincenzo, Castelli, Tommaso, Sorrenti, Valeria, Morgia, Giuseppe

Publikováno v: In The Journal of Urology April 2014 191(4) Supplement:e190-e190

Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study.

Autor: Morote, Juan, Gómez‐Caamaño, Antonio, de Celis, Raúl Poza, Gómez‐Veiga, Francisco, Ciria, Juan P., Calleja, Jesús, Extramiana, Javier, Pérez‐Sampietro, Maria, Perrot, Valerie, Angulo, Javier C.

Publikováno v: Neurourology & Urodynamics; Nov2022, Vol. 41 Issue 8, p1824-1833, 10p